Ovid Therapeutics (OVID) Change in Acquisitions & Divestments (2020 - 2025)
Historic Change in Acquisitions & Divestments for Ovid Therapeutics (OVID) over the last 5 years, with Q3 2025 value amounting to $10.0 million.
- Ovid Therapeutics' Change in Acquisitions & Divestments changed 0.0% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.0 million, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of $128.0 million for FY2024, which is 666.67% up from last year.
- As of Q3 2025, Ovid Therapeutics' Change in Acquisitions & Divestments stood at $10.0 million, which was down 0.0% from $17.0 million recorded in Q2 2025.
- Over the past 5 years, Ovid Therapeutics' Change in Acquisitions & Divestments peaked at $60.0 million during Q4 2022, and registered a low of $10.0 million during Q4 2023.
- In the last 4 years, Ovid Therapeutics' Change in Acquisitions & Divestments had a median value of $30.0 million in 2022 and averaged $28.8 million.
- As far as peak fluctuations go, Ovid Therapeutics' Change in Acquisitions & Divestments plummeted by 8333.33% in 2023, and later skyrocketed by 28000.0% in 2024.
- Quarter analysis of 4 years shows Ovid Therapeutics' Change in Acquisitions & Divestments stood at $60.0 million in 2022, then plummeted by 83.33% to $10.0 million in 2023, then surged by 280.0% to $38.0 million in 2024, then crashed by 73.68% to $10.0 million in 2025.
- Its Change in Acquisitions & Divestments stands at $10.0 million for Q3 2025, versus $17.0 million for Q2 2025 and $10.0 million for Q1 2025.